RT Avi Chawla (@_avichawla)This should be impossible!You can clean any ML dataset in just three lines of code. Flag outliers, find label errors, and more, across:- Any data (tabular, text, image, etc.)- Any task (classification, entity recognition, etc.)100% open-source, built by MIT researchers. https://t.co/xAaKjK4zIM ...

Core Insights - AT&T, Inc. has experienced a 20% stock price increase over the past year, significantly outperforming the Wireless National industry's growth of 4% [1] - The company has also outperformed competitors such as Verizon and Comcast, which saw declines of 7.9% and 29.5% respectively during the same period [2] Investment and Growth Strategy - AT&T has invested $145 billion in wireline and wireless networks from 2020 to 2024, positively impacting key sectors of the American economy, including transportation and logistics [4] - The company is focusing on small and mid-sized businesses by simplifying network complexities, enhancing connectivity, and integrating built-in security systems [3] - AI and machine learning capabilities are being deployed to optimize network services, including the AT&T Geo Modeler, which enhances network performance during adverse conditions [5] Customer Growth and Fiber Expansion - In the second quarter, AT&T added 243,000 fiber customers and aims to reach over 50 million fiber locations by the end of 2030, supported by the One Big Beautiful Bill Act [6] Competitive Landscape - The wireline division faces challenges due to losses in access lines from competition with VoIP providers and aggressive offerings from cable companies [10] - Intense competition from industry leaders like Verizon and Comcast poses additional challenges, particularly in the fiber expansion initiative [11] Financial Performance and Valuation - Earnings estimates for AT&T for 2025 and 2026 have remained stable over the past 60 days, with current estimates at $2.05 for 2025 and $2.25 for 2026 [12] - AT&T's shares are trading at a price/earnings ratio of 11.72, which is lower than the industry average of 12.5, indicating a relatively cheaper valuation [13]

Overview - Bittensor is a decentralized AI network gaining attention for its innovative approach [1][2] - The industry is observing the transformation of AI through Bittensor's decentralized internet of artificial intelligence [2] Token Performance - TAO, Bittensor's native token, has surpassed $1,000 [1] Technological Advancement - The network fosters competition and collaboration among machine learning models [2] - This approach leads to faster, smarter, and more efficient AI [2] - Bittensor aims to make AI accessible to everyone [2]

Indian lenders are increasingly using Artificial Intelligence and Machine Learning (AI, ML) in their core operations, including credit appraisal, enhancing customer experience, building new products and Treasury management, say senior bankers.Praveen Kutty, MD and CEO, DCB Bank, says the lender is using AI and ML across multiple access points, including bots, e-mails, voice interaction, risk mitigation and product modifications. “Using speech haptics and AI, we are able to figure out the resolution quality ...

Group 1 - JPMorgan is seeking to patent a method for evaluating the quality of software code generated by a large language model (LLM) [1] - The process involves a user providing instructions and the LLM selecting an API to write the code, which is then executed to verify its correctness [2][3] - The system assesses the code's quality based on accuracy, reliability, robustness, and consistency [3] Group 2 - JPMorgan has previously sought patents to ensure accuracy, exploring machine learning and blockchain for fact-checking [4] - Other tech companies, such as Microsoft and IBM, are also addressing AI-related issues, including code generation accuracy and AI bias [4]

Core Insights - NextNRG, Inc. reported a preliminary revenue of $7.07 million for September 2025, reflecting a year-over-year growth of 229% from $2.15 million in September 2024 [4] - The company delivered 2.03 million gallons in September 2025, a 238% increase from 600,390 gallons in September 2024, indicating strong demand and market share expansion [4] - Year-to-date revenue through September 2025 reached approximately $58.6 million, more than double the full-year revenue of ~$27 million for 2024, showcasing significant operational growth [4] Financial Performance - September 2025 revenue showed a 7% sequential decrease compared to August's $7.56 million, attributed to normal month-to-month variability in commercial fleet operations [5][8] - Despite the sequential decline, the year-over-year growth trajectory remains strong with consistent triple-digit growth [5][8] Strategic Initiatives - The company is executing a multi-state expansion strategy while advancing its integrated energy platform, which includes developments in RenCast, smart microgrids, and wireless EV charging solutions [6] - Recent strategic milestones include initiatives focused on reducing monthly burn and the ongoing development of the Next Utility Operating System®, which utilizes AI for optimization across various energy infrastructures [7] Market Position - NextNRG is positioned as a pioneer in AI-driven energy innovation, integrating AI and machine learning into utility infrastructure, battery storage, and mobile fuel delivery [10][11] - The company operates one of the largest on-demand fueling fleets in the nation and is advancing wireless charging technologies to support fleet electrification [11]

Core Points - Salarius Pharmaceuticals has regained compliance with Nasdaq Listing Rule 5550(b)(1), the Equity Standard Requirement, as of October 10, 2025, following its earlier compliance with Listing Rule 5550(a)(2) on September 9, 2025 [1][2] Group 1: Compliance and Merger - The company is now fully compliant with all Nasdaq listing requirements, which is a significant step towards its planned merger with Decoy Therapeutics [2] - Salarius entered into a definitive merger agreement with Decoy Therapeutics on January 13, 2025, where Decoy will merge with a wholly owned subsidiary of Salarius, forming a new entity named Decoy Therapeutics [3] - Following the compliance notice, Salarius will be under a Mandatory Panel Monitor for one year, during which any non-compliance could lead to a delisting determination [4] Group 2: Merger Details and Pipeline - The merger is expected to create multiple value-creating opportunities through Decoy's pipeline of peptide conjugate therapeutics, which targets unmet medical needs in respiratory infectious diseases and GI oncology [5] - The combined company will focus on advancing Decoy's lead asset, a pan-coronavirus antiviral, and other programs targeting flu, COVID-19, RSV, and GI cancers [7] - Salarius' existing drug candidate, SP-3164, will be integrated into the new company's drug development strategy [5][6] Group 3: Company Backgrounds - Decoy Therapeutics is a preclinical-stage biotechnology company utilizing machine learning and AI for rapid design and manufacturing of peptide conjugate drug candidates [9] - Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company with two drug candidates focused on cancer treatment, including seclidemstat and SP-3164 [10][11]

If you found it insightful, reshare it with your network.Find me → @_avichawlaEvery day, I share tutorials and insights on DS, ML, LLMs, and RAGs.Avi Chawla (@_avichawla):This should be impossible!You can clean any ML dataset in just three lines of code. Flag outliers, find label errors, and more, across:- Any data (tabular, text, image, etc.)- Any task (classification, entity recognition, etc.)100% open-source, built by MIT researchers. https://t.co/xAaKjK4zIM ...

This should be impossible!You can clean any ML dataset in just three lines of code. Flag outliers, find label errors, and more, across:- Any data (tabular, text, image, etc.)- Any task (classification, entity recognition, etc.)100% open-source, built by MIT researchers. https://t.co/xAaKjK4zIM ...

This is the second story in our series on artificial intelligence being applied here and now, where it matters most. Last week, we brought you the story of the AI used by your doctor. This week, it's about your teacher, the one you depend on to educate your children, the one we all depend on to prepare the next generation of workers, the one that we all remember from our own childhood.-Whenever I talk to people about their experiences in education, they always name this one teacher who was so influential, a ...